Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/26/2000 | US6165472 Folyl-polyglutamate synthetase (fpgs) of s. pnuemoniae is necessary for a fully functional folate synthesis pathway. having a present benefit of being useful to screen compounds for antibiotic activity. |
12/26/2000 | US6165470 Hybrid macromolecules composed of albumin derivatives coupled to derivatives of the cd4 receptor having a normal or a higher affinity for the hiv-1 virus. |
12/26/2000 | US6165466 Antagonists of interleukin-15 |
12/26/2000 | US6165465 Immunologic enhancement of the somatogenic effect of somatotropin with an antibody |
12/26/2000 | US6165464 Monoclonal antibodies directed to the HER2 receptor |
12/26/2000 | US6165462 Sugar kinase |
12/26/2000 | US6165461 Tao protein kinases and methods of use therefor |
12/26/2000 | US6165460 Generation of immune responses to prostate-specific antigen (PSA) |
12/26/2000 | CA2203494C Energy transfer dyes with enhanced fluorescence |
12/26/2000 | CA2089119C Hydrated silica and purification of dna |
12/26/2000 | CA2046646C Plants transformed to produce bacillus thuringiensis insecticidal toxins |
12/21/2000 | WO2000077523A1 Biosensors which utilize charge neutral conjugated polymers |
12/21/2000 | WO2000077293A1 Electrophoresis-assisted staining of materials |
12/21/2000 | WO2000077262A1 Synthetic ligation reassembly in directed evolution |
12/21/2000 | WO2000077260A1 Genomic profiling: a rapid method for testing a complex biological sample for the presence of many types of organisms |
12/21/2000 | WO2000077256A1 48 human secreted proteins |
12/21/2000 | WO2000077255A1 49 human secreted proteins |
12/21/2000 | WO2000077254A1 Detection of streptococcus pneumoniae and immunization against streptococcus pneumoniae infection |
12/21/2000 | WO2000077250A2 Method for circularizing oligonucleotides around a double stranded nucleic acid, resulting structures and uses thereof |
12/21/2000 | WO2000077249A1 METHOD FOR PRODUCING COMPLEX MIXTURES OF cDNA AND USES OF SAID MIXTURES FOR GENE EXPRESSION ANALYSIS |
12/21/2000 | WO2000077243A2 CoRT-PCR ASSAY FOR THE DISCRIMINATION OF ENDOGENOUS REVERSE TRANSCRIPTASE ACTIVITY IN EUKARYOTIC CELL LINES FROM INFECTIOUS RETROVIRUS CONTAMINATION |
12/21/2000 | WO2000077237A1 49 human secreted proteins |
12/21/2000 | WO2000077236A2 Methods for enhancing the production of cytokines in cell cultur e |
12/21/2000 | WO2000077235A1 Agent and process for isolation of extra-chromosomal nucleic acids |
12/21/2000 | WO2000077233A2 Complement-resistant non-mammalian dna viruses and uses thereof |
12/21/2000 | WO2000077232A1 Promoters from atlantic salmon |
12/21/2000 | WO2000077231A1 Regulatory sequences for animal cells and recombinant expression vectors |
12/21/2000 | WO2000077230A1 High-efficiency agrobacterium-mediated transformation of cotton using petiole explants |
12/21/2000 | WO2000077229A2 R1 protein from wheat and the use thereof for the production of modified strach |
12/21/2000 | WO2000077227A1 Fibrin sealant as a transfection/transformation vehicle for gene therapy |
12/21/2000 | WO2000077226A1 22025, a novel human cyclic nucleotide phosphodiesterase |
12/21/2000 | WO2000077225A1 A novel insulin signaling molecule |
12/21/2000 | WO2000077224A1 Method of increasing the content of fatty acids in plant seeds |
12/21/2000 | WO2000077223A1 Promoter enabling transgene expression in the whole plant except in the seed |
12/21/2000 | WO2000077222A1 Genes encoding enzymes in the biosynthesis of pimaricin and the application thereof |
12/21/2000 | WO2000077221A1 Hyaluronidase from the hirudinaria manillensis, isolation, purification and recombinant method of production |
12/21/2000 | WO2000077219A1 Method for determining hiv-1 subtype |
12/21/2000 | WO2000077218A1 Vaccine for newcastle disease virus |
12/21/2000 | WO2000077217A1 Nodavirus-based dna expression vector and uses thereof |
12/21/2000 | WO2000077216A2 Porcine circovirus vaccine in recombinant poxvirus |
12/21/2000 | WO2000077215A1 Cdc68p CHROMATIN REMODELING FACTOR |
12/21/2000 | WO2000077214A2 Characterization of the yeast transcriptome |
12/21/2000 | WO2000077213A2 Avirulent brucella and uses thereof |
12/21/2000 | WO2000077212A1 Bacteriocin, preparation and use thereof |
12/21/2000 | WO2000077211A1 Pyrexia-associated genes and pyrexia-associated proteins of plant |
12/21/2000 | WO2000077210A1 Equine granulocyte-macrophage colony-stimulating factor (gm-csf) |
12/21/2000 | WO2000077209A1 Helical cytokine zalpha33 |
12/21/2000 | WO2000077208A2 Gustatory receptors in drosophila |
12/21/2000 | WO2000077207A2 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto |
12/21/2000 | WO2000077206A2 The myostatin gene promoter and inhibition of activation thereof |
12/21/2000 | WO2000077205A1 HUMAN NUCLEAR FACTORS ASSOCIATED WITH dsRNA (NFAR) |
12/21/2000 | WO2000077204A1 Variant tlr4 nucleic acid and uses thereof |
12/21/2000 | WO2000077203A1 Lipocalin family protein |
12/21/2000 | WO2000077202A1 Novel compounds |
12/21/2000 | WO2000077201A1 Livin; inhibitor-of-apoptosis protein-3 (iap-3) |
12/21/2000 | WO2000077200A1 Receptor interacting protein rip3 |
12/21/2000 | WO2000077199A1 Cloning and expression of a novel 5-ht4 receptor |
12/21/2000 | WO2000077198A2 Identification and molecular characterisation of proteins, expressed in the tick salivary glands |
12/21/2000 | WO2000077197A1 47 human secreted proteins |
12/21/2000 | WO2000077196A1 Gene and protein sequences of phage t4 gene 35 |
12/21/2000 | WO2000077195A1 Nucleic acid encoding novel egf-like growth factors |
12/21/2000 | WO2000077194A1 A structured peptide scaffold for displaying turn libraries on phage |
12/21/2000 | WO2000077193A1 Enzyme selection |
12/21/2000 | WO2000077191A1 Tumor necrosis factor related receptor, tr6 |
12/21/2000 | WO2000077190A2 Induction of vascular endothelial growth factor (vegf) by the serine/threonine protein kinase akt |
12/21/2000 | WO2000077189A2 Method for the neogenesis of cell age |
12/21/2000 | WO2000077188A2 Dna pcv vaccine |
12/21/2000 | WO2000077187A2 Promoter system and production and use of the same |
12/21/2000 | WO2000077186A2 Bacterial protection against stress |
12/21/2000 | WO2000077185A2 Herbicide target genes and methods |
12/21/2000 | WO2000077184A1 Caspase-8 crystals, models and methods |
12/21/2000 | WO2000077182A1 Nucleic acid fragment and vector containing halogenase and method for the halogenation of chemical compounds |
12/21/2000 | WO2000077181A2 Dna manipulation methods, applications for synthetic enzymes and use for polyketide production |
12/21/2000 | WO2000077179A2 Human poly(adp-ribose) polymerase 2 materials and methods |
12/21/2000 | WO2000077177A2 Isolation of a human retrovirus |
12/21/2000 | WO2000077176A1 Method for obtaining low copy transgenes by direct dna transformation |
12/21/2000 | WO2000077175A1 Process of expressing and isolating recombinant proteins and recombinant protein products from plants, plant derived tissues or cultured plant cells |
12/21/2000 | WO2000077174A1 Process of expressing and isolating recombinant proteins and recombinant protein products from plants, plant derived tissues or cultured plant cells |
12/21/2000 | WO2000077173A1 42 human secreted proteins |
12/21/2000 | WO2000077172A1 Process for producing l-lysine |
12/21/2000 | WO2000077168A2 ANTAGONISTS OF BMP AND TGFβ SIGNALLING PATHWAYS |
12/21/2000 | WO2000077167A2 Herpes simplex virus amplicon vector targeting system and method of using same |
12/21/2000 | WO2000077166A2 Gene expression modulated in gastrointestinal inflammation |
12/21/2000 | WO2000077165A2 Expression in plants of starch binding domains and/or of protein fusions containing starch binding domains |
12/21/2000 | WO2000077081A1 Process for making fluorinated polymer adsorbent particles |
12/21/2000 | WO2000077047A1 Dog gonadotropin releasing hormone receptor |
12/21/2000 | WO2000077045A1 Novel protein and dna thereof |
12/21/2000 | WO2000077043A2 Dna vaccines for pets and sport animals |
12/21/2000 | WO2000077040A2 Human intracellular signaling molecules |
12/21/2000 | WO2000077037A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
12/21/2000 | WO2000077035A2 Novel potassium channels and genes encoding these potassium channels |
12/21/2000 | WO2000077032A2 Spermine:peptide-based surfactant compounds |
12/21/2000 | WO2000077026A1 49 human secreted proteins |
12/21/2000 | WO2000077023A1 48 human secreted proteins |
12/21/2000 | WO2000077022A1 50 human secreted proteins |
12/21/2000 | WO2000077021A1 48 human secreted proteins |
12/21/2000 | WO2000076954A1 Polyhydroxy diamine surfactants and their use in gene transfer |
12/21/2000 | WO2000076554A1 Ligand-conjugated oligomeric compounds |
12/21/2000 | WO2000076553A1 Use of viral vectors and charged molecules for gene therapy |
12/21/2000 | WO2000076542A1 Use of antibodies against cd20 for the treatment of the graft versus host disease |